Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJust Group Regulatory News (JUST)

Share Price Information for Just Group (JUST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.20
Bid: 103.00
Ask: 102.20
Change: 2.20 (2.14%)
Spread: -0.80 (-0.777%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 103.00
JUST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Tender Offer

14 Oct 2020 13:14

RNS Number : 0938C
Just Group PLC
14 October 2020
 

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (THE "UNITED STATES") OR IN OR INTO ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

 

Just Group plc announces the results of its tender offer in respect of its

£230,000,000 3.500 per cent. Subordinated Tier 3 Notes due 2025

14 October 2020. On 6 October 2020, Just Group plc1 (the "Offeror") announced an invitation to eligible holders ("Noteholders") of its £230,000,000 3.500 per cent. Subordinated Tier 3 Notes due 2025 (ISIN: XS1766956921) (the "Target Notes") to tender such Target Notes for purchase by the Offeror for cash up to the Final Acceptance Amount, subject to satisfaction of the New Financing Condition and on the terms and subject to the conditions described in a tender offer memorandum dated 6 October 2020 (the "Tender Offer Memorandum") prepared by the Offeror (the "Offer").

Capitalised terms used and not otherwise defined in this announcement shall have the meanings given in the Tender Offer Memorandum.

This is the results announcement referred to in the Tender Offer Memorandum.

Results of the Offer and acceptance

The Offeror announces that it will, subject to satisfaction of the New Financing Condition, accept valid tenders of the Target Notes pursuant to the Offer on the basis set out below:

Target Notes

Maturity Date

Nominal Amount Tendered

Final Acceptance Amount

Scaling Factor

Purchase Price (% of nominal)

Outstanding Nominal Amount after Settlement

3.500 per cent. Subordinated Tier 3 Notes due 2025

(ISIN: XS1766956921)

7 February 2025

£152,510,000

£75,000,000

48.9595%

94.25%

£155,000,000

New Financing Condition and Settlement of the Offer

The Offeror currently expects the New Financing Condition to be satisfied on 15 October 2020.

Subject to satisfaction or waiver by the Offeror of the New Financing Condition, the Settlement Date for the Offer is scheduled for 16 October 2020.

Total amount payable to Noteholders pursuant to the Offer

Subject to satisfaction of the New Financing Condition, upon settlement of the Offer the total amount that will be paid to each Noteholder on the Settlement Date in respect of the Target Notes accepted for purchase from such Noteholder will be an amount (rounded, if necessary, to the nearest £0.01, with £0.005 rounded upwards) equal to the sum of:

(a) the product of (i) the aggregate nominal amount of the Target Notes of such Noteholder accepted for purchase pursuant to the Offer and (ii) the Purchase Price of 94.25 per cent.; and

(b) the Accrued Interest Payment in respect of such Target Notes.

Further information

Morgan Stanley & Co. International plc is acting as Dealer Manager for the Offer and Lucid Issuer Services Limited is acting as Tender and Information Agent for the Offer. Their respective contact details are as follows:

Dealer Manager: Morgan Stanley & Co. International plc, 25 Cabot Square, Canary Wharf, London E14 4QA, United Kingdom. Telephone: +44 (0) 20 7677 5040; Email: liabilitymanagementeurope@morganstanley.com; Attn: Liability Management Group.

Tender and Information Agent: Lucid Issuer Services Limited, Tankerton Works, 12 Argyle Walk, London WC1H 8HA, United Kingdom. Telephone: +44 20 7704 0880; Email: justgroup@lucid-is.com; Attention: Mu-yen Lo.

---

1 The Legal Entity Identifier (LEI) of Just Group plc is: 5493006456YEZEELRR90

MARKET ABUSE REGULATION

This announcement is released by Just Group plc and contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 ("MAR"), encompassing information relating to the Offer described above. For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is made by Andy Parsons, Chief Financial Officer of Just Group plc.

DISCLAIMER: Neither this announcement nor the Tender Offer Memorandum constitutes an offer or an invitation to participate in the Offer in the United States or in any other jurisdiction in which, or to any person to or from whom, it is unlawful to make such offer or invitation or for there to be such participation under applicable laws. The distribution of this announcement and the Tender Offer Memorandum in certain jurisdictions may be restricted by law. Persons into whose possession this announcement or the Tender Offer Memorandum comes are required by each of the Offeror, the Dealer Manager and the Tender and Information Agent to inform themselves about and to observe any such restrictions.

The Expiration Deadline for the Offer has now passed and, accordingly, it is no longer possible to tender Target Notes pursuant to the Offer. The Offer was not made directly or indirectly in or into, or by use of the mail of, or by any means or instrumentality of interstate or foreign commerce of or of any facilities of a national securities exchange of, the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTEBDBDGXBBDGGS
Date   Source Headline
25th Apr 202410:04 amRNSDirector/PDMR Shareholding
12th Apr 202410:00 amRNSDirector/PDMR Shareholding
2nd Apr 20245:20 pmRNSDirector/PDMR Shareholding
26th Mar 20244:09 pmRNSHolding(s) in Company
26th Mar 20244:08 pmRNSHolding(s) in Company
26th Mar 20243:41 pmRNSAnnual Report and Accounts and Notice of AGM
8th Mar 20247:00 amRNSResults for the year ended 31 December 2023
7th Mar 20244:00 pmRNSHolding(s) in Company
6th Mar 20244:00 pmRNSHolding(s) in Company
4th Mar 20244:30 pmRNSHolding(s) in Company
5th Feb 20245:00 pmRNSHolding(s) in Company
31st Jan 20243:30 pmRNSHolding(s) in Company
26th Jan 20241:49 pmRNSHolding(s) in Company
25th Jan 20245:30 pmRNSDirector Declaration
22nd Jan 20244:43 pmRNSHolding(s) in Company
18th Jan 20244:55 pmRNSHolding(s) in Company
18th Jan 20247:00 amRNSBUSINESS UPDATE FOR YEAR ENDED 31 DECEMBER 2023
17th Jan 20244:12 pmRNSHolding(s) in Company
12th Jan 20243:01 pmRNSHolding(s) in Company
10th Jan 20241:31 pmRNSHolding(s) in Company
4th Jan 20244:25 pmRNSHolding(s) in Company
1st Dec 202311:32 amRNSBlock listing Interim Review
28th Nov 20233:00 pmRNSDirector/PDMR Shareholding
23rd Nov 20233:04 pmRNSDirectorate Change
13th Oct 202310:41 amRNSDirectorate Change
28th Sep 202310:13 amRNSDirector/PDMR Shareholding
16th Aug 20232:04 pmRNSHolding(s) in Company
15th Aug 20237:00 amRNSINTERIM RESULTS FOR THE SIX MONTHS ENDED 30/6/2023
20th Jul 20233:00 pmRNSHolding(s) in Company
18th Jul 20237:00 amRNSBusiness update for the six months to 30 June 2023
12th Jul 202310:34 amRNSDirectorate Change
11th Jul 20237:00 amRNSIFRS 17 FY 2022 and H1 22 restatement
6th Jul 20237:00 amRNSDirectorate Change
28th Jun 20239:36 amRNSHolding(s) in Company
1st Jun 202310:00 amRNSBlock listing Interim Review
25th May 20234:00 pmRNSHolding(s) in Company
9th May 20231:02 pmRNSResult of AGM
3rd May 20239:30 amRNSDirectorate Change
13th Apr 202312:05 pmRNSDirector/PDMR Shareholding
3rd Apr 202312:05 pmRNSDirector/PDMR Shareholding
24th Mar 20234:50 pmRNSAnnual Financial Report and Notice of AGM
24th Mar 202311:06 amRNSDirector/PDMR Shareholding
7th Mar 20237:00 amRNSResults for the year ended 31 December 2022
1st Mar 20231:08 pmRNSDirectorate Change
6th Feb 20237:00 amRNSIFRS 17 UPDATE
26th Jan 20237:00 amRNSBUSINESS UPDATE FOR THE YEAR ENDED 31 DEC 2022
5th Jan 202310:19 amRNSDirectorate Change
9th Dec 202212:15 pmRNSDirector/PDMR Shareholding
1st Dec 20221:32 pmRNSBlock listing Interim Review
11th Nov 202210:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.